Sort
39,280 grants matching “leukemia”
EASTERN COOPERATIVE ONCOLOGY GROUP
$413,121Vanderbilt University · U10 · FY2000 · CA
Genomic instability causes imatinib resistance in CML
$413,076Tomasz Skorski · Temple Univ Of The Commonwealth · R01 · FY2010 · CA
Community Clinical Oncology Program
$413,073David L Grinblatt · Northshore University Healthsystem · U10 · FY2007 · CA
Nanotechnology based magnetic detection for rare cell assays
$413,060Mark S. Diiorio · Magnesensors, Inc. · R44 · FY2008 · CA
Targeting Microenvironmental Signals in Myeloid Malignancies
$413,005Jeevisha Bajaj · University Of Rochester · R01 · FY2023 · CA
Assembly and Complementation of Viral Proteins during Retroviral Replication
$412,987Wei-Shau Hu · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
METHYLATION OF THE CALCITONIN GENE IN HUMAN TUMORS
$412,892Johns Hopkins University · R01 · FY2001 · CA
Leaders of Scientific Research Programs
$412,880Peter A Jones · University Of Southern California · P30 · FY2012 · CA
MOLECULAR STUDIES OF HEMATOPOIETIC STEM CELLS
$412,865Ihor R Lemischka · Icahn School Of Medicine At Mount Sinai · R37 · FY2009 · DK
Investigating the mechanism of SHP2 and BCL2 Inhibition in Acute Myeloid Leukemia (AML)
$412,854Catherine Choy Smith · University Of California, San Francisco · R01 · FY2023 · CA
Co-targeting S6 and TAM kinases in PTEN-deficient glioblastoma
$412,847David R Plas · University Of Cincinnati · R01 · FY2022 · CA
Co-targeting S6 and TAM kinases in PTEN-deficient glioblastoma
$412,847David R Plas · University Of Cincinnati · R01 · FY2023 · CA
Mechanisms of Apoptosis Dysregulation in AML
$412,847John C Reed · University Of Tx Md Anderson Can Ctr · P01 · FY2008 · CA
TET2-mediated transcriptional and epigenetic control of normal and malignant hematopoiesis
$412,845Mingjiang Xu · University Of Texas Hlth Science Center · R01 · FY2020 · HL
ROLE OF C/EBPalpha AND MYELOPOIESIS
$412,816Daniel G Tenen · Beth Israel Deaconess Medical Center · R01 · FY2010 · HL
ROLE OF C/EBPalpha AND MYELOPOIESIS
$412,812Daniel G Tenen · Beth Israel Deaconess Medical Center · R01 · FY2009 · HL
ROLE OF C/EBPalpha AND MYELOPOIESIS
$412,807Daniel G Tenen · Beth Israel Deaconess Medical Center · R01 · FY2008 · HL
Control of Erythroid Cell Division and Differentiation
$412,806Arthur I Skoultchi · Albert Einstein College Of Medicine · R01 · FY2008 · HL
ROLE OF C/EBPalpha AND MYELOPOIESIS
$412,772Daniel G Tenen · Beth Israel Deaconess Medical Center · R01 · FY2007 · HL
BIOMARKERS OF BENZENE EXPOSURE AND GENOTOXICITY
$412,755University Of California Berkeley · R01 · FY2003 · ES
The chromatin remodeler Mi2 in T cell development
$412,750Massachusetts General Hospital · R01 · FY2005 · AI
Strategies to improve the adoptive transfer of T cells
$412,706Stanley R Riddell · Fred Hutchinson Cancer Research Center · R01 · FY2013 · CA
Discovery of MAP2K7 Inhibitors Through DNA-Encoded Chemical Screens to Treat T-Cell Acute Lymphoblastic Leukemia
$412,685H. Daniel Lacorazza · Baylor College Of Medicine · R21 · FY2024 · CA
Biology and Prognostic Implications of FLT3 Mutations in AML
$412,589Soheil Meshinchi · Fred Hutchinson Cancer Research Center · R01 · FY2013 · CA
THE BIOLOGY OF PROMYELOCYTIC LEUKEMIA IN A MOUSE MODEL.
$412,588Washington University · R01 · FY2002 · CA